Page last updated: 2024-08-24

geranylgeraniol and Precancerous Conditions

geranylgeraniol has been researched along with Precancerous Conditions in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Conti, A; de Moura Espíndola, R; Heidor, R; Mazzantini, RP; Moreno, FS; Ong, TP	1

Other Studies

1 other study(ies) available for geranylgeraniol and Precancerous Conditions

Article	Year
Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-kappaB activation. Carcinogenesis, 2005, Volume: 26, Issue:6 Topics: Animals; Anticarcinogenic Agents; Apoptosis; Cell Proliferation; Cholesterol; Corn Oil; Diterpenes; DNA Damage; Enzyme Activation; Hepatocytes; Liver Neoplasms, Experimental; Male; NF-kappa B; Norisoprenoids; Precancerous Conditions; Rats; Rats, Wistar; Transcription Factor RelA	2005

Article

Year

Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-kappaB activation.

Carcinogenesis, 2005, Volume: 26, Issue:6

Topics: Animals; Anticarcinogenic Agents; Apoptosis; Cell Proliferation; Cholesterol; Corn Oil; Diterpenes; DNA Damage; Enzyme Activation; Hepatocytes; Liver Neoplasms, Experimental; Male; NF-kappa B; Norisoprenoids; Precancerous Conditions; Rats; Rats, Wistar; Transcription Factor RelA

2005